The launch of generic medicinal products is a very important issue to be present on the market from the first day after the expiry of the industrial property rights attached to the reference specialty (" princeps"). This launch "day-one" indeed conditions the acquisition of market shares against generic competitors. Launching "day-one" of a generic medicine: the issue of preparatory acts. Such a launch is not improvising and requires that all pr…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
The launch of generic medicinal products is a very important issue to be present on the market from the first day after the expiry of the industrial property rights attached to the reference specialty (" princeps"). This launch "day-one" indeed conditions the acquisition of market shares against generic competitors. Launching "day-one" of a generic medicine: the issue of preparatory acts. Such a launch is not improvising and requires that all pr…